|

Bosutinib Clinical Trials

3 actively recruiting trials across 2 locations

Other1 trial

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Phase 2

Ann Arbor, Michigan1 trial

Asciminib Roll-over Study

Michigan Med University of Michigan

Phase 4

Houston, Texas1 trial

Study of Olverembatinib (HQP1351) in Patients With CP-CML

MD Anderson Cancer Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.